Glioma tumors, glioma-derived cells and particularly GSCs are thought to be resistant to DNA damage treatment due to increased expression of the DNA repair machinery (6–9) and of select DNA damage response (DDR) genes (10,11), including PARP1, a critical DNA damage sensor and DNA repair coordinator (12). This evidence concerns the gene PARP1 and central nervous system cancer.